Abstracts Archive - Page 416 of 1683 - ATC Abstracts

2020 American Transplant Congress
A Single-Center Experience in Transfusion-Free Liver Transplantation: Referrals and Outcomes from 2005 to 2019
B. H. Horwich¹, A. Mulgaonkar¹, B. Kim², N. Kaur¹, J. Kahn², Y. Genyk³, A. Ahearn³, H. Han²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²GI & Liver Diseases, University of Southern California, Los Angeles, CA, ³Surgery, University of Southern California, Los Angeles, CA
*Purpose: The Jehovah’s Witnesses is a religious group known to the medical community for its non-acceptance of blood products. This poses a significant challenge in…
2020 American Transplant Congress
Unresolved Disparities: Sex, Racial, Ethnic, and Insurance Differences in Performance Status at Listing for Liver Transplant
R. Rosenblatt, B. Fortune, A. Jesudian, C. Lucero, R. S. Brown, B. Samstein, J. Emond, E. Verna, K. Halazun
Center for Liver Disease and Transplantation, New York, NY
*Purpose: Cirrhosis is a chronic disease characterized by progressive worsening in physical functioning. We hypothesized that poor performance status at time of listing was an…
2020 American Transplant Congress
Liver Transplantation in Patients Requiring Pre-Transplant Mechanical Ventilation
T. Ito, A. Aziz, A. E. Murray, S. Younan, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas
The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA
*Purpose: Increasing transplant candidate acuity has resulted in more patients requiring perioperative intensive care and mechanical ventilation prior to liver transplantation (LT). However, studies on…
2020 American Transplant Congress
Perioperative Extracorporeal Membrane Oxygenation (ECMO) in Liver Transplantation: A Case Series
J. G. Guorgui¹, T. Ito¹, M. M. Lu¹, P. Benharash², A. Ardehali³, V. Gudzenko⁴, C. Wray⁴, V. G. Agopian¹, J. DiNorcia III¹, H. Yersiz¹, D. G. Farmer¹, R. W. Busuttil¹, F. M. Kaldas¹
¹The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²Cardiovascular Outcomes Research Laboratories, UCLA, Los Angeles, CA, ³Division of Cardiac Surgery, Department of Surgery, UCLA, Los Angeles, CA, ⁴Department of Anesthesiology, UCLA, Los Angeles, CA
*Purpose: Extracorporeal Membrane Oxygenation (ECMO) is a life-saving treatment modality for patients who develop cardiopulmonary failure refractory to conventional efforts. ECMO has been used sparingly…
2020 American Transplant Congress
Predicting the Safe Use of Deceased after Circulatory Death Liver Allografts in Primary Sclerosing Cholangitis
V. Fleetwood, A. Gracon, D. Aufhauser, C. Papageorge, K. Janek, G. Leverson, D. Foley, J. Mezrich, A. D'Alessandro, L. Fernandez, D. Al-Adra
Department of Transplantation, University of Wisconsin, Madison, WI
*Purpose: The use of deceased after circulatory donation (DCD) liver allografts in patients with primary sclerosing cholangitis (PSC) is controversial given the already-increased risk of…
2020 American Transplant Congress
Rare Genetic Mutation Triggering Acute Liver Failure in a Toddler Needing a Liver Transplant
C. B. Chen¹, N. Mistry Ambani¹, A. Zeft¹, R. Garcia-Naviero², V. Hupertz¹, K. Hashimoto¹, K. Radhakrishnan¹
¹Cleveland Clinic, Cleveland, OH, ²Akron Children's Hospital, Akron, OH
*Purpose: The AIRE gene plays an important role in immune tolerance by driving negative selection of self-recognizing T-cells. Mutations in this gene are responsible for…
2020 American Transplant Congress
Frailty Assessment in Patients Undergoing Liver Transplant Evaluation: A Large Single Center Experience
H. Oduor, P. Mantry, L. Lesch, M. Alford, M. Pickle, M. Barnes, A. Habib, A. Mehta, A. Mejia, H. Nazario, M. Pagadala, V. Puri, Z. Vahora, J. Weinstein
The Liver Institute at Methodist Dallas, Dallas, TX
*Purpose: Frailty is a multi-component syndrome characterized by reduced physiologic reserve and functional decline. It is an independent predictor of poor post-transplant outcomes, including prolonged…
2020 American Transplant Congress
Liver Transplant Recipients with BMI 40 to <50 kg/m² Have Excellent Patient and Graft Survival
K. Daniel, J. Hause, F. Osman, J. Mezrich, E. Spengler
University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Obesity rates in the United States (US) have reached nearly 40%, which has led to an increasing proportion of liver transplant (LT) candidates with…
2020 American Transplant Congress
Sex-Dependent Resistance to Ischemia-Reperfusion Injury in Mouse and Human Liver Transplantation
S. Kageyama, H. Kojima, K. Kadono, H. Hirao, K. J. Dery, S. Younan, T. Ito, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec-Weglinski
Surgery, Dumont-UCLA Transplant Center, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) is a major risk factor for early allograft dysfunction and rejection in orthotopic liver transplantation (OLT). The influence of sex on…
2020 American Transplant Congress
Liver Transplantation for Pediatric Genetic and Metabolic Liver Disease: A Single-Center Experience
S. Hassan¹, K. Mysore¹, D. N. Cerminara², K. E. Hosek³, M. Faraone⁴, R. Sigereddi⁵, R. Ackah⁵, A. Rana⁶, J. Goss⁶, T. Galvan⁶
¹Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ²Pharmacy, Texas Children's Hospital, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ³Outcomes and Impact Service, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁴Department of Surgery, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁵Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁶Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX
*Purpose: Pediatric liver transplantation (LT) is an established treatment for a myriad of liver diseases most notably biliary atresia and urea cycle defects. In the…